Abstract
The aging population is an undeniable reality which must be faced by all health systems all over the world. Among people over 80 years old, increase in stroke incidence, high mortality rates and adverse outcomes are problems of major public concern. Lack of evidence-based data to guide rational decision making on vascular risk factors management to avoid recurrence in elderly stroke patients increases the areas of uncertainty, and sometimes favors medical inertia at the time of taking care of this growing elderly population.
Keywords: Clopidogrel, diabetes, abdominal obesity, dyslipidemia, transient ischemic attack, morbidity, secondary prevention, vascular risk factors, very old, Stroke
Cardiovascular & Hematological Disorders-Drug Targets
Title: Is It Possible to Apply Secondary Stroke Prevention Guidelines to Very Old Populations?
Volume: 11 Issue: 1
Author(s): Laura Brescacin
Affiliation:
Keywords: Clopidogrel, diabetes, abdominal obesity, dyslipidemia, transient ischemic attack, morbidity, secondary prevention, vascular risk factors, very old, Stroke
Abstract: The aging population is an undeniable reality which must be faced by all health systems all over the world. Among people over 80 years old, increase in stroke incidence, high mortality rates and adverse outcomes are problems of major public concern. Lack of evidence-based data to guide rational decision making on vascular risk factors management to avoid recurrence in elderly stroke patients increases the areas of uncertainty, and sometimes favors medical inertia at the time of taking care of this growing elderly population.
Export Options
About this article
Cite this article as:
Brescacin Laura, Is It Possible to Apply Secondary Stroke Prevention Guidelines to Very Old Populations?, Cardiovascular & Hematological Disorders-Drug Targets 2011; 11(1) . https://dx.doi.org/10.2174/187152911795945150
DOI https://dx.doi.org/10.2174/187152911795945150 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Angiogenetic Potential of Ad2/Hif-1α/Vp16 after Regional Application in a Preclinical Pig Model of Chronic Ischemia
Current Vascular Pharmacology The GH/IGF-1 Axis in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?
Current Pharmaceutical Design The Spatial QRS-T Angle: Implications in Clinical Practice
Current Cardiology Reviews Mechanisms of Enhanced Vasoconstriction in the Mouse Model of Atherosclerosis: the Beneficial Effects of Sildenafil
Current Pharmaceutical Biotechnology Animal Models of Diabetes Mellitus: Relevance to Vascular Complications
Current Pharmaceutical Design Multiple Sclerosis: Current and Future Treatment Options
Endocrine, Metabolic & Immune Disorders - Drug Targets The Biological and Clinical Activity of Anti-Malarial Drugs In Autoimmune Disorders
Current Rheumatology Reviews Biochemical Markers of Cardiovascular Damage from Tobacco Smoke
Current Pharmaceutical Design Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design Meet the Editorial Board
Current Drug Targets Cardiovascular Proteomics
Current Proteomics Bcl-2 Family Proteins Regulate Apoptosis and Epithelial to Mesenchymal Transition by Calcium Signals
Current Pharmaceutical Design Cardiovascular Magnetic Resonance for Evaluation of Heart Involvement in ANCA-Associated Vasculitis. A Luxury or a Valuable Diagnostic Tool?
Inflammation & Allergy - Drug Targets (Discontinued) Cardiac Amyloid - A Hidden Contributor to Cardiac Dysfunction Following Cardiac Surgery: Case Report and Literature Review
Current Cardiology Reviews Calreticulin in the Heart: From Embryological Development to Cardiac Pathology.
Current Molecular Medicine Artificial Intelligence for Epigenetics: Towards Personalized Medicine
Current Medicinal Chemistry Titin and Troponin: Central Players in the Frank-Starling Mechanism of the Heart
Current Cardiology Reviews Adult Stem Cells and Skeletal Muscle Regeneration
Current Gene Therapy Effect of Aging on Metabolic Pathways in Endothelial Progenitor Cells
Current Pharmaceutical Design